Intestinal failure associated liver disease (IFALD) is frequent problem encountered when managing patients receiving parenteral nutrition (PN). Its occurrence is often multifactorial and modification of these factors is vital for the management of such hepatic dysfunction. The use of novel lipid preparations can form part of this management strategy. We present a case whereby such modification of contributing factors, including lipid preparations, led to improvements in IFALD and reversal of hepatic fibrosis.
Reversal of intestinal failure associated liver disease fibrosis in a patient receiving long term home parenteral nutrition / Bond, A.*; Hayes, S.; Abraham, A.; Teubner, A.; Farrer, K.; Pironi, L.; Lal, S.. - In: CLINICAL NUTRITION ESPEN. - ISSN 2405-4577. - ELETTRONICO. - 28:(2018), pp. 228-231. [10.1016/j.clnesp.2018.09.002]
Reversal of intestinal failure associated liver disease fibrosis in a patient receiving long term home parenteral nutrition
Pironi, L.;
2018
Abstract
Intestinal failure associated liver disease (IFALD) is frequent problem encountered when managing patients receiving parenteral nutrition (PN). Its occurrence is often multifactorial and modification of these factors is vital for the management of such hepatic dysfunction. The use of novel lipid preparations can form part of this management strategy. We present a case whereby such modification of contributing factors, including lipid preparations, led to improvements in IFALD and reversal of hepatic fibrosis.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
